Arvinas Inc.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (NCT07749586) | Arvinas Inc. | 2026-07-29 |
| A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation (NCT07023731) | Arvinas Inc. | 2025-05-29 |
| A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery (NCT05549505) | Arvinas Inc. | 2023-02-15 |
| Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer (NCT03888612) | Arvinas Inc. | 2019-03-01 |
Track Arvinas Inc. automatically
Every clearance here is in the API, with alerts when new ones post.